BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bouzid D, Kammoun A, Amouri A, Mahfoudh N, Haddouk S, Tahri N, Makni H, Masmoudi H. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping. Genet Test Mol Biomarkers. 2012;16:482-487. [PMID: 22224635 DOI: 10.1089/gtmb.2011.0132] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Muro M, López-Hernández R, Mrowiec A. Immunogenetic biomarkers in inflammatory bowel diseases: Role of the IBD3 region. World J Gastroenterol 2014; 20(41): 15037-15048 [PMID: 25386052 DOI: 10.3748/wjg.v20.i41.15037] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
2 Wu XR, Liu XL, Katz S, Shen B. Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis. Inflamm Bowel Dis. 2015;21:703-715. [PMID: 25687266 DOI: 10.1097/mib.0000000000000227] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
3 Moini M, Saadat M, Saadat H, Esmailnejad A, Safarpour A. Association Study of Glutathione S-transferases Gene Polymorphisms (GSTM1 and GSTT1) with Ulcerative Colitis and Crohn's Disease in the South of Iran. Adv Biomed Res 2017;6:67. [PMID: 28626742 DOI: 10.4103/2277-9175.190981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
4 Aheman A, Gao F, Kuerbanjiang A, Li YX, Abuduhadeer M. Difference in DRB1* gene polymorphisms between Han and Uyghur ulcerative colitis patients in China. World J Gastroenterol 2013; 19(17): 2709-2713 [PMID: 23674880 DOI: 10.3748/wjg.v19.i17.2709] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
5 Alboini PE, Spagni G, Evoli A. In sickness and in health: when myasthenia gravis is a conjugal matter. Neurol Sci 2021;42:2099-101. [PMID: 33409825 DOI: 10.1007/s10072-020-04944-y] [Reference Citation Analysis]
6 Kunovsky L, Dite P, Jabandziev P, Kala Z, Vaculova J, Andrasina T, Hrunka M, Bojkova M, Trna J. Autoimmune Diseases of Digestive Organs-A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation. J Clin Med 2021;10:5796. [PMID: 34945093 DOI: 10.3390/jcm10245796] [Reference Citation Analysis]
7 Martinez-Orozco FJ, Vicario JL, De Andres C, Fernandez-Arquero M, Peraita-Adrados R. Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study. J Clin Med Res 2016;8:495-505. [PMID: 27298657 DOI: 10.14740/jocmr2569w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
8 Ohayon MM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med 2013;14:488-92. [PMID: 23643648 DOI: 10.1016/j.sleep.2013.03.002] [Cited by in Crossref: 130] [Cited by in F6Publishing: 121] [Article Influence: 14.4] [Reference Citation Analysis]
9 Kamoun A, Bouzid D, Mahfoudh N, Amouri A, Gaddour L, Hakim F, Tahri N, Masmoudi H, Makni H. Association study of MICA-TM polymorphism with inflammatory bowel disease in the South Tunisian population. Genet Test Mol Biomarkers. 2013;17:615-619. [PMID: 23822824 DOI: 10.1089/gtmb.2012.0423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Ewald PW, Swain Ewald HA. An evolutionary perspective on the causes and treatment of inflammatory bowel disease: . Current Opinion in Gastroenterology 2013;29:350-6. [DOI: 10.1097/mog.0b013e328361f80f] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Gao F, Aheman A, Lu JJ, Abuduhadeer M, Li YX, Kuerbanjiang A. Association of HLA-DRB1 alleles and anti-neutrophil cytoplasmic antibodies in Han and Uyghur patients with ulcerative colitis in China. J Dig Dis 2014;15:299-305. [PMID: 24597629 DOI: 10.1111/1751-2980.12143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
12 Ashton JJ, Latham K, Beattie RM, Ennis S. Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease. Aliment Pharmacol Ther 2019;50:885-900. [PMID: 31518029 DOI: 10.1111/apt.15485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
13 Kevadiya BD, Ottemann BM, Thomas MB, Mukadam I, Nigam S, McMillan J, Gorantla S, Bronich TK, Edagwa B, Gendelman HE. Neurotheranostics as personalized medicines. Adv Drug Deliv Rev 2019;148:252-89. [PMID: 30421721 DOI: 10.1016/j.addr.2018.10.011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 11.7] [Reference Citation Analysis]